share_log

Allarity Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Graff Jeremy R.

Allarity Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Graff Jeremy R.

Allarity Therapeutics | 3:首次持股聲明-高管 Graff Jeremy R.
美股SEC公告 ·  10/01 17:35

Moomoo AI 已提取核心訊息

Jeremy R. Graff, President and Chief Development Officer of Allarity Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 09/30/2024, indicates that Graff does not beneficially own any securities in the company. The filing was made in accordance with Section 16(a) of the Securities Exchange Act of 1934 and is a standard procedure for individuals in Graff's position, providing transparency about the holdings of company insiders. The form was filed by Graff as a single reporting person and was signed on 10/01/2024.
Jeremy R. Graff, President and Chief Development Officer of Allarity Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 09/30/2024, indicates that Graff does not beneficially own any securities in the company. The filing was made in accordance with Section 16(a) of the Securities Exchange Act of 1934 and is a standard procedure for individuals in Graff's position, providing transparency about the holdings of company insiders. The form was filed by Graff as a single reporting person and was signed on 10/01/2024.
Allarity Therapeutics有限公司總裁兼首席開發官Jeremy R. Graff已根據證券交易委員會要求的表格3的規定提交了一份有關有利所有權的證券的初始申報書。此文檔日期爲2024年09/30,表明Graff並不持有該公司的任何證券。該申報是根據1934年證券交易法第16(a)條的規定進行的,對於Graff這個職位的個人而言,這是一個標準程序,可透明地展示公司內部人士的持股情況。該表格由Graff作爲單一報告人提交,並於2024年10/01簽署。
Allarity Therapeutics有限公司總裁兼首席開發官Jeremy R. Graff已根據證券交易委員會要求的表格3的規定提交了一份有關有利所有權的證券的初始申報書。此文檔日期爲2024年09/30,表明Graff並不持有該公司的任何證券。該申報是根據1934年證券交易法第16(a)條的規定進行的,對於Graff這個職位的個人而言,這是一個標準程序,可透明地展示公司內部人士的持股情況。該表格由Graff作爲單一報告人提交,並於2024年10/01簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息